We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




MERS Surge Remains Unexplained

By HospiMedica International staff writers
Posted on 19 May 2014
The dramatic increase in Middle East Respiratory Syndrome (MERS) coronavirus cases in late March and early April of 2014 raises troubling questions.

MERS shares characteristics similar to severe acute respiratory syndrome (SARS) coronavirus. More...
But while its genes have been sequenced and tests for infection created, the natural history of the disease remains unclear, and there is no specific treatment or vaccine. In the early months of the MERS outbreak, the virus had a very high case-fatality rate that is still hovering around 30%, despite an increased number of confirmed cases without symptoms. In the early stages, about 15 cases were reported each month. But more than 250 cases have been reported by the Kingdom of Saudi Arabia (KSA) since March 22, more than half of the 421 cases reported to date.

According to the World Health Organization (Geneva, Switzerland), the sweeping surge in MERS cases, especially among healthcare workers, appears in large measure to be due to problems with infection control practices in some KSA hospitals. This appears to mirror a similar trajectory as SARS, which also spread well in hospitals. About 20% of the roughly 8,500 SARS patients identified were health-care workers, and people in hospital for other health ailments also made up a substantial portion of SARS sufferers.

Another factor implicated is that a recent change in KSA policy of who to test for MERS infection—i.e., not just sick people, but seemingly healthy contacts as well—is also inflating the country's MERS tally. This testing change is identifying significant numbers of people who are infected, but have mild or no apparent symptoms. But while the steep climb in cases alone is a cause for concern, a more serious problem is that KSA and the United Arab Emirates (UAE) have been exporting MERS cases.

Malaysia, the Philippines, Jordan, Egypt, and Greece have all recently reported diagnosing MERS in people returning from Saudi Arabia or the UAE. In April 2014, the United States disclosed it had found its first MERS case, a US citizen who lives and works in the health-care sector in the KSA capital of Riyadh. And with Ramadan—the Muslim month of fasting—starting at the end of June, the potential for exported cases among the hundreds of thousands of Hajj pilgrims is considerable.

“The Saudis themselves are extremely aware of the issues, and so they're very conscious that they want to make sure that people coming to visit and people leaving are not either posing a danger to other pilgrims in Saudi Arabia or not spreading infection to the rest of the world,” said Keiji Fukuda, MD, a senior WHO official. “I think they're very conscious about that, and very responsible about that. But it's a difficult situation, because people want to go on pilgrimages. So balancing all of those things requires some careful thinking and discussion about how to get that balance right.”

Recent studies support a theory that camels serve as the primary source of the MERS coronavirus infecting humans, while bats may be the ultimate reservoir of the coronavirus. Evidence includes the frequency with which the virus has been found in camels to which human cases have been exposed, serological data which shows widespread transmission in camels, and the similarity of the camel coronavirus to the human coronavirus.

Related Links:

World Health Organization




Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Mobile X-Ray System
K4W
Gas Consumption Analyzer
Anesthetic Gas Consumption Analyzer
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The AI-based approach identifies lipid regions matched well with histopathology results (Photo courtesy of Hyeong Soo Nam/KAIST)

AI-Based OCT Image Analysis Identifies High-Risk Plaques in Coronary Arteries

Lipid-rich plaques inside coronary arteries are strongly associated with heart attacks and other major cardiac events. While optical coherence tomography (OCT) provides detailed images of vessel structure... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.